PlainPharmaWatch

CMS Open Payments · Tool

Mylan Specialty L.P. vs Senseonics, Incorporated

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Senseonics, Incorporated has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 762, versus 51 for the other company. Its single largest recorded recipient represents 0.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Mylan Specialty L.P.
HHI 51 · top recipient 0.0%
Ranked #1,760 of 1,838 companies by HHI
Senseonics, Incorporated
HHI 762 · top recipient 0.2%
Ranked #1,144 of 1,838 companies by HHI

Payment Overview

Total Payments
$2.9M
% of Industry
0.0%
Transactions
29,170
Avg per Transaction
$99.92
Recipients
29,055
Avg per Recipient
$100.32
Payment Types
6
Top Payment Type
Food and Beverage
Total Payments
$2.9M
% of Industry
0.0%
Transactions
372
Avg per Transaction
$7.8K
Recipients
141
Avg per Recipient
$20.6K
Payment Types
4
Top Payment Type
Compensation for Services Other Than Consulting

Highlighted values indicate the higher figure for each metric.

Total payments compared

Mylan Specialty L.P. vs Senseonics, Incorporated - total reported payments in CMS Open Payments PY2024

Mylan Specialty L.P.$2.9MSenseonics, Incorporated$2.9M

Payment Types Breakdown

Mylan Specialty L.P.

Food and Beverage $660.9K

22.7%

Compensation for Services Other Than Consulting $555.7K

19.1%

Consulting Fee $90.6K

3.1%

Travel and Lodging $52.4K

1.8%

Space Rental or Facility Fees $22.2K

0.8%

Education $3.6K

0.1%

Senseonics, Incorporated

Compensation for Services Other Than Consulting $45.1K

1.6%

Consulting Fee $12.3K

0.4%

Travel and Lodging $7.9K

0.3%

Food and Beverage $83.65

0.0%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Mylan Specialty L.P.

  1. 1

    TARUN MADAPPA

    $35,432.16 · 40 txns

  2. 2

    SANDRA SCHULDHEISZ

    $26,017.65 · 45 txns

  3. 3

    JEFFREY WOLF

    $25,577.16 · 41 txns

  4. 4

    LACEY KRISTIN MATHEIS

    $22,952.97 · 40 txns

  5. 5

    WILLIAM ALLEYNE

    $21,952.64 · 17 txns

Senseonics, Incorporated

  1. 1

    KASHIF A LATIF

    $12,048.10 · 7 txns

  2. 2

    GRACE CARLSON

    $8,937.50 · 4 txns

  3. 3

    Natasha Gibbs

    $7,670.30 · 17 txns

  4. 4

    Heidi A Jennings

    $2,369.72 · 10 txns

  5. 5

    Gary Graf

    $2,000.00 · 5 txns

Summary Comparison

Metric Mylan Specialty L.P. Senseonics, Incorporated
Total Payments $2.9M $2.9M
% of Industry Total 0.0% 0.0%
Transaction Count 29,170 372
Avg per Transaction $99.92 $7.8K
Recipient Count 29,055 141
Avg per Recipient $100.32 $20.6K
Payment Type Count 6 4
Top Payment Type Food and Beverage Compensation for Services Other Than Consulting

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.